The results from three Phase I …
Read News ArticleCategory: Latest News
FDA Extends Review of Ocrevus™ (ocrelizumab)
On December 20, 2016, Genentec …
Read News ArticleHighlights from the 2016 ECTRIMS Annual Meeting
More than 9,000 clinicians and …
Read News ArticleMake Your Voice Heard on MS Treatment
The Institute for Clinical and …
Read News ArticleExperimental SPMS Medication Shows Positive Results
A Phase III study with siponim …
Read News ArticleThe Multiple Sclerosis Association of America Launches Online Support Community for Individuals Affected by MS
The Multiple Sclerosis Associa …
Read News ArticleHighlights from the AAN and CMSC Annual Meetings
Two vital conferences providin …
Read News ArticleMy MS Manager Named One of the Best MS Apps of 2016
My MS Manager™, MSAA’s free mo …
Read News ArticleFDA Accepts Review of Application for Ocrelizumab
On June 27, 2016, Genentech, a …
Read News ArticleEligible People with PPMS May Receive Experimental Medication
Ocrelizumab, an experimental m …
Read News Article